Clinical Trial Update: Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial update on GRASPA (erythrocyte-encapsulated L-asparaginase) in elderly patients with first-line acute lymphoblastic leukemia; results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• GRASPA (L-asparaginase encapsulated in red blood cells)

Snippet

Sponsor: ERYtech Pharma | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2018-06-14